These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15551291)

  • 1. Case of relapsed CD20(+) mixed-cellularity Hodgkin disease treated with sequential rituximab and radiotherapy.
    Karamouzis MV; Apostolikas N; Georganta C; Lainakis G; Kandylis K; Rigatos G
    Am J Hematol; 2004 Dec; 77(4):418-9. PubMed ID: 15551291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK; Wittekind C; Niederwieser D
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of rituximab in patients with recurrent, classic Hodgkin disease.
    Younes A; Romaguera J; Hagemeister F; McLaughlin P; Rodriguez MA; Fiumara P; Goy A; Jeha S; Manning JT; Jones D; Abruzzo LV; Medeiros LJ
    Cancer; 2003 Jul; 98(2):310-4. PubMed ID: 12872350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.
    Maeda LS; Advani RH
    Curr Opin Oncol; 2009 Sep; 21(5):397-400. PubMed ID: 19606035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in lymphocyte-predominant Hodgkin disease.
    Azim HA; Pruneri G; Cocorocchio E; Cinieri S; Raviele PR; Bassi S; Preda L; Martinelli G; Peccatori FA
    Oncology; 2009; 76(1):26-9. PubMed ID: 19033694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin V genes in Reed-Sternberg cells.
    Trümper L; Daus H; Gause A; Pfreundschuh M
    N Engl J Med; 1996 Feb; 334(6):404-5; author reply 405-6. PubMed ID: 8538725
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Naparstek E
    Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified.
    Hirata Y; Yokote T; Kobayashi K; Nakayama S; Miyoshi T; Akioka T; Hara S; Tsuji M; Takubo T; Hanafusa T
    Leuk Res; 2009 Jun; 33(6):e13-6. PubMed ID: 18995899
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.
    Stern M; Herrmann R; Rochlitz C; Dirnhofer S; Pless M
    Eur J Haematol; 2005 Mar; 74(3):267-70. PubMed ID: 15693799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease.
    Portlock CS; Donnelly GB; Qin J; Straus D; Yahalom J; Zelenetz A; Noy A; O'Connor O; Horwitz S; Moskowitz C; Filippa DA
    Br J Haematol; 2004 Jun; 125(6):701-8. PubMed ID: 15180859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma of the iris.
    Economou MA; Kopp ED; All-Ericsson C; Seregard S
    Acta Ophthalmol Scand; 2007 May; 85(3):341-3. PubMed ID: 17488468
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
    Lacouture ME; Baron JM; Jani AB; Laumann AE; Soltani K
    Clin Exp Dermatol; 2005 Jan; 30(1):46-8. PubMed ID: 15663503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal anti-CD20 antibody therapy].
    Juhel L; Solal-Celigny P
    Rev Prat; 2004 Apr; 54(7):711-2. PubMed ID: 15253285
    [No Abstract]   [Full Text] [Related]  

  • 18. The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
    Rawal YB; Nuovo GJ; Frambach GE; Porcu P; Baiocchi RA; Magro CM
    J Cutan Pathol; 2005 Oct; 32(9):616-21. PubMed ID: 16176299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin V genes in Reed-Sternberg cells.
    Tbakhi A; Sreenan J; Tubbs RR
    N Engl J Med; 1996 Feb; 334(6):405-6. PubMed ID: 8538726
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-CD20 monoclonal antibody therapy in multiple myeloma.
    Kapoor P; Greipp PT; Morice WG; Rajkumar SV; Witzig TE; Greipp PR
    Br J Haematol; 2008 Apr; 141(2):135-48. PubMed ID: 18318769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.